Moreover, IDH1 levels in plasma of lung squamous cell carcinoma and lung adenocarcinoma patients were significantly elevated compared to benign lung disease patients and healthy individuals, suggesting IDH1 as a potential plasma biomarker for the diagnosis of NSCLCs [66]. This evidence concerns the gene IDH1 and squamous cell lung carcinoma.